These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26932341)

  • 1. Patients with Psoriatic Arthritis Fulfilling the Minimal Disease Activity Criteria Do Not Have Swollen and Tender Joints, but Have Active Skin.
    Marin J; Acosta Felquer ML; Ferreyra Garrot L; Ruta S; Rosa J; Soriano ER
    J Rheumatol; 2016 May; 43(5):907-10. PubMed ID: 26932341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application and modifications of minimal disease activity measures for patients with psoriatic arthritis treated with adalimumab: subanalyses of ADEPT.
    Mease PJ; Heckaman M; Kary S; Kupper H
    J Rheumatol; 2013 May; 40(5):647-52. PubMed ID: 23504383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
    Michelsen B; Diamantopoulos AP; Hammer HB; Soldal DM; Kavanaugh A; Haugeberg G
    Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
    Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical remission in patients with active psoriatic arthritis treated with adalimumab and correlations in joint and skin manifestations.
    Van den Bosch F; Kavanaugh A; Kron M; Kupper H; Mease PJ
    J Rheumatol; 2015 Jun; 42(6):952-9. PubMed ID: 25834212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual Disease Activity and Associated Factors in Psoriatic Arthritis.
    Lubrano E; Scriffignano S; Perrotta FM
    J Rheumatol; 2020 Oct; 47(10):1490-1495. PubMed ID: 31676704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis.
    Sheane BJ; Thavaneswaran A; Gladman DD; Chandran V
    J Rheumatol; 2016 Sep; 43(9):1718-23. PubMed ID: 27422895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis.
    Chaudhry SR; Thavaneswaran A; Chandran V; Gladman DD
    Rheumatology (Oxford); 2013 Apr; 52(4):705-11. PubMed ID: 23267168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement.
    van Mens LJJ; Turina MC; van de Sande MGH; Nurmohamed MT; van Kuijk AWR; Baeten DLP
    Rheumatology (Oxford); 2018 Feb; 57(2):283-290. PubMed ID: 28541484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
    Cauli A; Gladman DD; Mathieu A; Olivieri I; Porru G; Tak PP; Sardu C; Ujfalussy I; Scarpa R; Marchesoni A; Taylor WJ; Spadaro A; Fernàndez-Sueiro JL; Salvarani C; Kalden JR; Lubrano E; Carneiro S; Desiati F; Flynn JA; D'Angelo S; Vacca A; VAN Kuijk AW; Catanoso MG; Gruenke M; Peluso R; Parsons WJ; Ferrara N; Contu P; Helliwell PS; Mease PJ;
    J Rheumatol; 2011 May; 38(5):898-903. PubMed ID: 21324965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort.
    van Mens LJJ; van de Sande MGH; van Kuijk AWR; Baeten D; Coates LC
    Ann Rheum Dis; 2018 Feb; 77(2):251-257. PubMed ID: 29080861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
    Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT;
    J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease.
    Coates LC; FitzGerald O; Gladman DD; McHugh N; Mease P; Strand V; Helliwell PS
    Arthritis Rheum; 2013 Jun; 65(6):1504-9. PubMed ID: 23529837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.
    Coates LC; Gottlieb AB; Merola JF; Boone C; Szumski A; Chhabra A
    J Rheumatol; 2019 Feb; 46(2):160-165. PubMed ID: 30323006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the patient's and the physician's perspective of disease in psoriatic arthritis.
    Dandorfer SW; Rech J; Manger B; Schett G; Englbrecht M
    Semin Arthritis Rheum; 2012 Aug; 42(1):32-41. PubMed ID: 22424812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM; Marchesoni A; Lubrano E
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis.
    Kumar R; Sharma A; Dogra S
    Indian J Dermatol Venereol Leprol; 2014; 80(1):15-23. PubMed ID: 24448118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.